About
Solutions
Pipeline
Publications
News
Careers
CN
Open main menu
News
Loading...
Track Our News on
2023-07-29
ICML 2023 | Rethinking Explaining Graph Neural Networks via Non-parametric Subgraph Matching
2023-07-18
MindRank Secures Over $20 Million in A+ Round Financing, Propelling Innovative Drug Pipeline and AI Platform Commercialization
2023-06-12
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
2023-04-05
Commun. Chem. (Nature) | Pharmacophoric-Constrained Heterogeneous Graph Transformer Model for Molecular Property Prediction
2023-01-17
MindRank Made the List of 2022 China's Top 10 Most Potential ScienceAI Startups by Synced
2023-01-12
MindRank was Nominated for the 2022 Venture50 List by Zero2IPO Group and Pedaily
2022-12-23
MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity
2022-12-19
MindRank was Nominated "the TOP100 Most Innovative Medical Technology Products (Solutions) 2022" by VBDATA
2022-12-16
MindRank Features in the 2022 Galen Growth | Global HealthTech Insights HealthTech 250 List
2022-12-06
MindRank is Awarded the 4th China Health Innovation Platform Award
2022-11-25
MindRank’s Co-Authorship Paper Won the 2021 Chinese Scientists with Cell Press Best Paper Award
2022-11-05
MindRank Features in EqualOcean 2022 China AI Health 30 Companies List
Previous
2 / 4
Next
Previous
2 / 4
Next
